Skip to main content

Ana Daniela Ulloa Navas

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Ana Daniela Ulloa Navas

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Alex Rovira Rincón

Alex Rovira Rincón

Research technician
Clinical Neuroimmunology
Read more
Lucia Iglesias Sanchez

Lucia Iglesias Sanchez

Research technician
Molecular Imaging and Therapy
Read more
Jose Angel Jimenez Lasanta

Jose Angel Jimenez Lasanta

Research technician
Molecular Imaging and Therapy
Read more
Helena Ortin i Berga

Helena Ortin i Berga

Predoctoral researcher
Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.